ACLS Provider: Course

Incorrect. The jaw thrust maneuver opens the airway without manipulating the cervical spine, protecting against spinal cord injury.

Incorrect. The same compression rate as adults ensures adequate perfusion in pediatric patients during CPR.

Incorrect. Asystole is a non-shockable rhythm and is treated with high-quality CPR and epinephrine administration.

Incorrect. Oxygen saturation should be maintained at 92-96% to prevent hypoxia and avoid the harmful effects of hyperoxia.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore an organized rhythm.

Incorrect. PETCO2 monitoring provides continuous feedback on the quality of chest compressions and the effectiveness of resuscitation.

Incorrect. Epinephrine is the first-line drug for VF, with amiodarone as the preferred antiarrhythmic for refractory cases.

Incorrect. Delivering 6-8 breaths per minute minimizes interruptions in chest compressions and prevents hyperventilation.

Incorrect. Magnesium sulfate stabilizes cardiac myocytes and is the drug of choice for treating torsades de pointes.

Incorrect. Atropine should not exceed a total dose of 3 mg when treating symptomatic bradycardia in adults.

Incorrect. Post-ROSC care focuses on optimizing oxygenation, ventilation, and hemodynamic stability to prevent further organ damage.

Incorrect. Maintains vasoconstriction, improving blood flow to vital organs during resuscitation.

Incorrect. Synchronized cardioversion is indicated for unstable atrial fibrillation to restore sinus rhythm and prevent hemodynamic collapse.

Incorrect. Adenosine is the first-line drug for stable SVT, while synchronized cardioversion is used for unstable SVT.

Incorrect. Atropine blocks vagal stimulation, increasing heart rate in cases of symptomatic bradycardia.

Incorrect. IM epinephrine is the first-line treatment for anaphylaxis, administered into the mid-thigh for rapid absorption.

Incorrect. PETCO2 monitoring ensures effective ventilation and provides feedback on the quality of chest compressions during CPR.

Incorrect. The correct dose of epinephrine for pediatric cardiac arrest is 0.01 mg/kg IV/IO, not 1 mg/kg.

Incorrect. Waveform capnography ensures proper ET tube placement by continuously monitoring exhaled CO? levels.

Incorrect. Immediate defibrillation is the most effective intervention for a witnessed cardiac arrest in VF.

Incorrect. Prompt defibrillation within 30 seconds of witnessed VF arrest improves the chance of restoring a perfusing rhythm.

Incorrect. Delivering 6-8 breaths per minute ensures adequate oxygenation without hyperventilation during CPR with an advanced airway.

Incorrect. Placing hands on the lower half of the sternum ensures effective chest compressions without damaging other structures.

Incorrect. Prevents progression to cardiac arrest by restoring a normal rhythm.

Incorrect. Providing 6-8 breaths per minute ensures adequate oxygenation and ventilation without interfering with chest compressions.

Incorrect. Epinephrine is given at a dose of 1 mg IV/IO every 3-5 minutes during adult cardiac arrest to improve perfusion.

Incorrect. Maintaining oxygen saturation within this range ensures adequate oxygenation without the risk of hyperoxia.

Incorrect. The two-thumb encircling technique provides high-quality compressions for infants during CPR.

Incorrect. Synchronized cardioversion is used for unstable atrial fibrillation to restore organized electrical activity.

Incorrect. A compression fraction >80% is required to maximize perfusion and improve survival rates during high-quality CPR.

Incorrect. PEA is not treated with adenosine; it is managed with CPR, epinephrine, and identifying and treating reversible causes.

Incorrect. Pulseless VT is treated with defibrillation, while synchronized cardioversion is reserved for tachyarrhythmias with a pulse.

Incorrect. A rate of 100-120 compressions per minute ensures adequate circulation without risking incomplete recoil or excessive fatigue.

Incorrect. Synchronized cardioversion restores organized cardiac activity in unstable atrial flutter.

Incorrect. Ventilations are delivered every 6-8 seconds to provide oxygenation without interrupting chest compressions.

Incorrect. Chest compressions are performed to dislodge the obstruction and restore effective ventilation in an unresponsive infant.

Incorrect. Delivering 10 breaths per minute ensures adequate oxygenation without causing hyperventilation.

Incorrect. High-quality CPR should be resumed immediately after defibrillation to maintain perfusion and increase chances of ROSC.

Incorrect. Compressing one-third the depth of the chest ensures adequate perfusion while minimizing the risk of injury.

Incorrect. Epinephrine is administered every 3-5 minutes during cardiac arrest to maximize coronary and cerebral perfusion.

Incorrect. Epinephrine is given first in VF during cardiac arrest, followed by amiodarone as an antiarrhythmic after defibrillation attempts.

Incorrect. PETCO2 monitoring provides real-time feedback on chest compressions and the effectiveness of CPR.

Incorrect. Amiodarone is used after defibrillation and epinephrine for refractory VF to stabilize the myocardium.

Incorrect. Interruptions in chest compressions should not exceed 10 seconds to maintain adequate perfusion to vital organs.

Incorrect. For biphasic defibrillators, 120-200 J is the recommended energy range for VF.

Incorrect. A compression fraction greater than 80% ensures that most of the resuscitation time is spent performing chest compressions.

Incorrect. Adenosine is the first-line drug for treating narrow-complex SVT by slowing conduction through the AV node.

Incorrect. PETCO2 >10 mmHg during CPR indicates effective chest compressions generating sufficient circulation.

Incorrect. Adenosine is administered as a rapid IV push at an initial dose of 6 mg to terminate stable SVT.

Incorrect. IO access provides a reliable alternative for rapid drug delivery during resuscitation when IV access cannot be obtained.

Incorrect. A 30:2 ratio ensures sufficient oxygenation and circulation in adults during CPR without an advanced airway.

Incorrect. Synchronized cardioversion restores organized cardiac activity in unstable VT with a pulse, preventing progression to VF.

Incorrect. PETCO2 levels greater than 10 mmHg suggest that chest compressions are generating adequate circulation.

Incorrect. Pediatric defibrillation starts at 2 J/kg to safely deliver an effective shock without causing harm.

Incorrect. Oxygen saturation should be maintained at 92-96% to avoid hypoxia and reduce the risk of hyperoxia and oxidative stress.

Incorrect. Biphasic defibrillation begins at 120-200 J to terminate shockable rhythms like VF and pulseless VT effectively.

Incorrect. Naloxone is used to reverse opioid overdose, restoring respiratory effort in patients with respiratory depression.

Incorrect. Atropine doses should not exceed 3 mg during bradycardia management to avoid adverse effects.

Incorrect. Pulse checks should be limited to 10 seconds to minimize interruptions in chest compressions.

Incorrect. Needle decompression relieves pressure caused by tension pneumothorax, improving ventilation and circulation.

Incorrect. Compressions at 1/3 the depth of the chest ensure adequate perfusion while minimizing injury to internal organs.

Incorrect. Epinephrine is administered every 3-5 minutes during pediatric cardiac arrest to enhance coronary and cerebral perfusion.

Incorrect. High-quality CPR is the primary treatment for asystole, along with epinephrine and addressing reversible causes.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and treat torsades de pointes effectively.

Incorrect. Switching compressors every 2 minutes reduces rescuer fatigue, ensuring high-quality chest compressions are maintained.